Page last updated: 2024-08-23

nigericin and Idiopathic Pulmonary Fibrosis

nigericin has been researched along with Idiopathic Pulmonary Fibrosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellaye, PS; Beltramo, G; Bonniaud, P; Boutanquoi, PM; Burgy, O; Causse, S; Garrido, C; Goirand, F; Wettstein, G	1

Other Studies

1 other study(ies) available for nigericin and Idiopathic Pulmonary Fibrosis

Article	Year
Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin. Respiratory research, 2016, 11-29, Volume: 17, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Bleomycin; Caspase 1; Caspase Inhibitors; Cell Line; Cytoprotection; Disease Models, Animal; Humans; Idiopathic Pulmonary Fibrosis; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Lung; Mice, Inbred C57BL; Nigericin; Pleura; Signal Transduction; Time Factors; Transforming Growth Factor beta1	2016

Article

Year

Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin.

Respiratory research, 2016, 11-29, Volume: 17, Issue:1

Topics: Animals; Anti-Inflammatory Agents; Bleomycin; Caspase 1; Caspase Inhibitors; Cell Line; Cytoprotection; Disease Models, Animal; Humans; Idiopathic Pulmonary Fibrosis; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Lung; Mice, Inbred C57BL; Nigericin; Pleura; Signal Transduction; Time Factors; Transforming Growth Factor beta1

2016